USE OF PICOPLATIN TO TREAT PROSTATE CANCER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120122825A1
SERIAL NO

13319647

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides a method of treatment of metastatic hormone-refractory prostate cancer involving substantially as concurrent administration of picoplatin and docetaxel. Prednisone may also be administered. Dosages and dosing regimens are provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PONIARD PHARMACEUTICALS INCWASHINGTON STATE WASHINGTON

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Breitz, MD Hazel B Seattle, US 1 1
Jager, Robert De Rancho Santa Fe, US 2 1
Karlin, MD David A Los Altos, US 1 1
Weiden, MD Paul L Seattle, US 1 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation